These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10891021)

  • 21. Evaluation of the efficacy of treatment of Kawasaki disease before day 5 of illness.
    Fong NC; Hui YW; Li CK; Chiu MC
    Pediatr Cardiol; 2004; 25(1):31-4. PubMed ID: 14534763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of giant coronary artery aneurysms in Kawasaki disease by intravenous gamma globulin therapy.
    Rowley AH; Duffy CE; Shulman ST
    J Pediatr; 1988 Aug; 113(2):290-4. PubMed ID: 2456378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and management of Kawasaki disease.
    Gersony WM
    JAMA; 1991 May 22-29; 265(20):2699-703. PubMed ID: 2023352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary treatment of incomplete Kawasaki disease with infliximab and methylprednisolone in a patient with a contraindication to intravenous immune globulin.
    Shirley DA; Stephens I
    Pediatr Infect Dis J; 2010 Oct; 29(10):978-9. PubMed ID: 20431427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management and outcome of intravenous gammaglobulin-resistant Kawasaki disease.
    Sittiwangkul R; Pongprot Y; Silvilairat S; Phornphutkul C
    Singapore Med J; 2006 Sep; 47(9):780-4. PubMed ID: 16924360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of unresponsiveness to standard high-dose gamma globulin therapy in Kawasaki disease].
    Tavli V; Yilmazer MM; Güven B; Meşe T; Oner T; Demirpençe S
    Turk Kardiyol Dern Ars; 2010 Jan; 38(1):20-4. PubMed ID: 20215838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effective use of echocardiography in children with Kawasaki disease.
    Scott JS; Ettedgui JA; Neches WH
    Pediatrics; 1999 Nov; 104(5):e57. PubMed ID: 10545583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
    Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S
    J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease.
    Furukawa S; Matsubara T; Umezawa Y; Motohashi T; Ino T; Yabuta K
    Eur J Pediatr; 1994 Sep; 153(9):663-7. PubMed ID: 7957426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do we have a less severe form of Kawasaki disease or is it the gammaglobulin effect?
    Abushaban L; Salama A; Uthaman B; Kumar A; Selvan J
    Int J Cardiol; 1999 Apr; 69(1):71-6. PubMed ID: 10362375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous gamma-globulin for Kawasaki disease.
    Furusho K; Kamiya T; Nakano H; Kiyosawa N; Shinomiya K; Hayashidera T; Tamura T; Hirose O; Manabe Y; Yokoyama T
    Acta Paediatr Jpn; 1991 Dec; 33(6):799-804. PubMed ID: 1801560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of Kawasaki disease.
    Nakashima L; Edwards DL
    Clin Pharm; 1990 Oct; 9(10):755-62. PubMed ID: 2242655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recognition and management of Kawasaki disease.
    Han RK; Sinclair B; Newman A; Silverman ED; Taylor GW; Walsh P; McCrindle BW
    CMAJ; 2000 Mar; 162(6):807-12. PubMed ID: 10750471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gamma globulin re-treatment in Kawasaki disease.
    Sundel RP; Burns JC; Baker A; Beiser AS; Newburger JW
    J Pediatr; 1993 Oct; 123(4):657-9. PubMed ID: 8410524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic impact of vascular leakage in acute Kawasaki disease.
    Terai M; Honda T; Yasukawa K; Higashi K; Hamada H; Kohno Y
    Circulation; 2003 Jul; 108(3):325-30. PubMed ID: 12835221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of coronary artery aneurysms after Kawasaki disease.
    Akagi T; Rose V; Benson LN; Newman A; Freedom RM
    J Pediatr; 1992 Nov; 121(5 Pt 1):689-94. PubMed ID: 1432415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of inadequate initial echocardiography in suspected Kawasaki disease: Criteria for sedation.
    Lorenzoni RP; Choi J; Choueiter NF; Munjal IM; Katyal C; Stern KWD
    Congenit Heart Dis; 2018 May; 13(3):470-475. PubMed ID: 29520958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iv gamma globulin treatment of Kawasaki disease in Japan: results of a nationwide survey.
    Yanagawa H; Yashiro M; Nakamura Y; Sakata K; Kawasaki T
    Acta Paediatr; 1995 Jul; 84(7):765-8. PubMed ID: 7549294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Kawasaki disease in children--9 years experience].
    Kowalczyk M; Kawalec W; Daszkowska-York J; Turska-Kmieć A; Brzezińska-Rajszys G; Sobielarska D; Ziółkowska L; Kościesza A; Jagiełłowicz D; Mirecka-Rola A
    Med Wieku Rozwoj; 2005; 9(2):179-93. PubMed ID: 16085959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kawasaki Disease and Clinical Outcome Disparities Among Black Children.
    Padilla LA; Collins JL; Idigo AJ; Lau Y; Portman MA; Shrestha S
    J Pediatr; 2021 Feb; 229():54-60.e2. PubMed ID: 32980379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.